Abstract: Plant-derived diterpenoids serve as important pharmaceuticals,f ood additives,a nd fragrances,y et their low natural abundance and high structural complexity limits their broader industrial utilization. By mimicking the modularity of diterpene biosynthesis in plants,w ec onstructed 51 functional combinations of class Iand II diterpene synthases,41ofwhich are "new-to-nature". Stereoselective biosynthesis of over 50 diterpene skeletons was demonstrated, including natural variants and novel enantiomeric or diastereomeric counterparts. Scalable biotechnological production for four industrially relevant targets was accomplished in engineered strains of Saccharomyces cerevisiae.
Diterpenoids are ad iverse class of structurally complex natural products with broad therapeutic applications.P lants provide the major source of these chemicals and present arich reservoir of potentially new pharmaceuticals.Exploitation of this diversity is severely limited by difficulties in extracting pure compounds from natural sources on an industrial scale. Alternatives include semisynthesis from naturally occurring precursors,p lant cell cultures,a nd chemical synthesis. [1] Stereospecific synthetic routes for complex diterpenoids often remain commercially impracticable owing to their low efficiency. [2] Combinatorial metabolic engineering of microbial or plant hosts,u sing the enzymes of the biosynthetic pathways,offers an alternative environmentally benign access to structurally complex diterpenoids with specific and novel stereochemistry,w hich often defines the therapeutic value.
[3]
Thec arbon skeletons of bi-and polycyclic labdanes and clerodanes are formed in at wo-step enzyme reaction catalyzed by bifunctional class I/II diterpene synthases (diTPSs) or pairs of distinct monofunctional diTPSs defined by their catalytic activity as class Io rc lass II enzymes.
[4]
Class II diTPSs catalyze the initial cyclization of (E,E,E)-geranylgeranyl diphosphate (GGPP) into bicyclic diphosphate intermediates with ac haracteristic decalin core (Scheme 1). Thes tructure and specific stereochemistry at the C9 and C10 carbon atoms of the intermediate are determined by the class II diTPS catalyzed reaction. The subsequent class IdiTPS reaction completes the formation of the diterpene skeleton through dephosphorylation of the class II product and specific rearrangements,a dditional cyclizations,o rw ater addition, thereby resulting in the introduction of additional chiral centers (Scheme 1).
[4b]
We have recently identified ad iverse suite of 40 class II and class Id iTPSs from ten plant species,e ach harboring structurally exceptional diterpenoids. [5] In plants,s pecific pairs of class Ia nd class II diTPSs form distinct diterpene skeletons,w hich underpins the structural diversity of native diterpenoids.
[6] To explore the inherent metabolic potential and plasticity of modular combinations of diTPSs,wesystematically paired diTPSs through co-expression in heterologous hosts.S pecifically,w ep robed the substrate and product plasticity for every combination of eleven class II and nine class Id iTPSs representative of diverse plant species and potential functionalities.E ight functionally uncharacterized diTPSs were included in this approach (Table S1 in the Supporting Information).
We report herein the stereoselective formation of more than 50 labdane-and clerodane-type skeletons through the assembly of combinations of diTPS pairs.These skeletons are labelled throughout (1-47)a ccording to their Kovats retention indices ( Figure S1 -4 and Table S2 in the Supporting Information). Theaa nd bs uffixes indicate (+ +)o rent configurations,r espectively,a ss hown by chiral GC-MS analysis,NMR, and optical rotation measurements of selected purified compounds.T hree examples illustrate the potential of this approach for control of the stereochemical configuration of diterpenes through specific selection of class II diTPSs and for extension of the known structural repertoire of skeletons accessible by biosynthesis through combination with class IdiTPSs.Alist of all of the diterpenes produced is given in Table S2 .
DiTPS combinations were tested by Agrobacterium tumefaciens mediated transient expression in Nicotiana benthamiana and the results were supported by in vitro assays with recombinant diTPS expressed and purified from E. coli for each type of class II diTPS.T od emonstrate fermentation-based diterpene production, selected diTPS combinations were introduced into engineered Saccharomyces cerevisiae to yield target molecules at ascale relevant for industrial consideration.
Comparison of substrate and product profiles showed that the class Id iTPSs show distinct degrees of substrate and product plasticity with regards to the stereochemistry and hydroxylation pattern of the diphosphate substrate.S pecifically,i natotal of 12 combinations,asubset of six class I diTPSs converted the two stereoisomers of labda-13-en-8-ol diphosphate [(+ +)-8-LPP and ent-8-LPP,F igure 1].
Thed iscrete formation of three stereoisomers of the diterpene manoyl oxide highlights how biosynthetic routes can be stereoselectively controlled ( Figure 2 ). (13R)-(+ +)-manoyl oxide (16 a), ap recursor for the diterpenoid pharmaceutical forskolin, [6a] was formed from (+ +)-8-LPP by the combination of Salvia sclarea SsLPPS with Marrubium vulgare MvTPS5 at 3.7 times higher levels than the native combination of CfTPS2 and CfTPS3 from Coleus forskohlii, which may be relevant for future production. Stereoselective access to manoyl oxide stereoisomers is aprerequisite for the biotechnological production of forskolin derivatives with novel stereochemical configurations.I nc ombination with the class II diTPS Tw TPS21 from Tripterygium wilfordii, CfTPS3 catalyzed the stereoselective formation of (13R) [8] Thef ormation of structurally distinct bicyclic diterpenes, such as sclareol, which is used in high-end fragrance manufacture,i sc atalyzed in S. sclarea by SsLPPS and SsSCS. [9] Antibiotic activities have been reported for ac ompound of this class,(+ +)-manool, [10] which is also recognized as as tarting material for the semisynthesis of aw ide range of diterpenoids with pharmaceutical properties. [11] SsSCS was used as ar epresentative of class Id iTPSs that, following rearrangement, facilitate neutralization of the carbocation through water quenching at C13 to give regiospecific introduction of ahydroxy group. [9] When offered the three known stereoisomers of copalyl diphosphate (CPP), SsSCS formed products with the stereochemistry preserved at the chiral centers C9 and C10, as defined by the class II diTPSs. Specifically,t he pairing of SsSCS with diTPSs forming ent-CPP,( + +)-CPP,o rsyn-CPP,r esulted in the stereoselective formation of ent-manool (23 b), (+ +)-manool (23 a), and synmanool (11), respectively,both in N. benthamiana and in vitro (Figure 2 , Figure S16 , and Tables S4, S5). Upon identification of the new combination of diTPSs that efficiently yields 23 a, CfTPS1 and SsSCS were codon optimized and stably integrated into the genome of astrain of S. cerevisiae engineered for diterpene production to afford 23 a at 310 mg L À1 (Table S9) , thereby effectively tripling previously reported titers. [12] Theh ighly efficient conversion of bicyclic diphosphate intermediates by SsSCS proved instrumental in elucidating the function of an uncharacterized class II diTPS.T he combination of Tw TPS14 with SsSCS produced ac ompound consistent with ad iTPS function new to plants and only recently reported in the bacterium Herpetosiphon aurantia- Angewandte Chemie Communications cus. [13] Purification and NMR analysis established the structure as kolavelool (26), from the distinct class of clerodanetype diterpenes (Table S6) .
[4b] These diterpenes have been reported from arange of plant species and form the skeleton of salvinorin A, al ead drug candidate for the treatment of mental disorders and substance dependence, [14] yet the biosynthetic route remains unknown. Similarly,c oupling of two functionally uncharacterized class II diTPSs with the nine class Id iTPSs and comparison of the product profiles with those of established enzymes enabled the classification of EpTPS7 and Tw TPS7 as ent-CPP synthases (Figure 2) . Furthermore,c ombining ent-CPP synthases with EpTPS8 or EpTPS23 resulted in the formation of ent-neoabietadiene and ent-dehydroabietadiene,r espectively ( Figure S14 ), diterpene scaffolds not previously reported in nature.L ikewise,t he Tw TPS21/SsSCS combination yielded ent-sclareol, which constitutes the first biosynthetic route to this specific stereoisomer.
Several of the combinations provided skeletons of highvalue diterpenoids,f or example,m iltiradiene (25), the backbone of cardioprotectives (tanshinones) [15] and antioxidants (carnosoic acid), [16] 16 a and 23 a as precursors for the drug forskolin, [6a] and the synthetic ambergris substitute (À)-ambrox, which is used in high-end fragrances. [17] Fors tereoselective production of these targets,e xpression-optimized variants of CfTPS1/CfTPS3, CfTPS2/CfTPS3, and Tw TPS21/ EpTPS1 were introduced stably into the genome of a S. cerevisiae strain engineered for diterpene production. Production titers between 250-370 mg L À1 (Table S9 ) underline the potential for scale-up production by fermentation.
In summary,w es how that engineered diTPS combinations can be used to expand the biosynthetically accessible repertoire of diterpene skeletons with superior stereochemical control. Our approach meets al ong-standing desire for control over the stereochemical configuration of synthesized diterpenes,w hich remains ac hallenge in formal chemical synthesis.W ith chiral molecules representing more than half of approved drugs worldwide,collectively valued at over $200 billion in 2008, [18] our findings make an important contribution to accelerate drug development and demonstrate how synthetic biology can complement chemical synthesis for the production of stereochemically complex small molecules.
Experimental Section
Generationofexpressionconstructs,expression in N. benthamiana, S. cerevisiae and E. coli,e xtraction analysis of products,a nd structural elucidationbyNMR were done as previously described and are given in supplementary material and methods. [6a, 19] Figure 1 . The diterpene chemoscape. A) Levels of diterpenes accumulating in the N. benthamiana/Agrobacterium system (n = 3). B) GC-MS chromatograms of extracts from the N. benthamiana control, CfTPS1/ SsSCS expressed in N. benthamiana or in S. cerevisiae,t he in vitro assay,and an authentic standard of (9S,1(0S-manool(23 a). Total ion current (TIC) and extracted-ion chromatogram(EIC) levels are not to scale. C) 2D representation of diterpenes detected in N. benthamiana expressinge ither asingle diTPS or combinations of diTPSsf rom the two classes (y axis). Diterpenes are sorted on the x axis by their Kovats retention indices. Cf = C. forskohlii;S s= S. sclarea;M v= M. vulgare; Ep = Euphorbia peplus;O s= O. sativa;T w= T. wilfordii;Zm= Z. mays. Diterpenes in samples expressing solely class II diTPSs are likely the result of endogenous phosphatase activity and non-specific rearrangement ( Figure S7 ). [6a, 7] Angewandte Figure 2 . Combinatorialw heel. Formation of diterpenes by natural and engineered diTPS combinations. Bonds in aspecified stereochemical configuration formed through stereoselective controlled synthesis are highlighted in red. Bonds in aspecified stereochemical configuration for which there is no biosynthetic access to the other configuration are shown in black. The aa nd bsuffixes indicate (+ +)and ent configurations, respectively,asd ictated by the class II diTPS. Diterpenes with unknown structure are shaded in grey.*indicates clerodane diterpenes.
